Evaluation of neonatal hearing screening results of newborns with premature retinopathy.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
May 2022
Historique:
received: 27 11 2021
revised: 29 01 2022
accepted: 15 03 2022
pubmed: 25 3 2022
medline: 27 4 2022
entrez: 24 3 2022
Statut: ppublish

Résumé

To reveal the risk situations of ROP patients in terms of hearing loss by examining the newborn hearing screening test results. Hearing screening test results of ROP patients and newborns with similar congenital risk factors(control group) treated in our hospital were retrospectively screened. Both groups were compared in terms of newborn hearing screening test results. In the first screening test, the rate of ''refer'' result in the ROP group was significantly higher than the control group (p < 0.05). There was no significant difference between the two groups in terms of second hearing screening test results (p > 0.05). In the second screening test, 100% of stage 3 ROP patients failed from the right ear and 80% in the left ear, and this difference was statistically significant compared to the other two groups (p < 0.05). Newborn hearing screenings of patients with advanced stage ROP patients should be followed up more sensitively, since stage 3 ROP patients had more failure results from the screening test in our study.

Identifiants

pubmed: 35325847
pii: S0165-5876(22)00073-8
doi: 10.1016/j.ijporl.2022.111112
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111112

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Hilal Yücel (H)

Department of Otorhinolaryngology Head and Neck Surgery, Konya City Hospital, University of Health Sciences, Konya, Turkey. Electronic address: hilaldemirx@yahoo.com.

Osman Sayın (O)

Department of Eye Diseases, Konya Health Application and Research Hospital, University of Health Sciences, Konya, Turkey. Electronic address: drosmansayin@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH